Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy

Journal of Urology

Volumn 169, Issue 4, 2003, Pages 1325-1330

  Freedland, Stephen J ^a   DeGregorio, Frank ^c   Sacoolidge, John C ^c   Elshimali, Yahya I ^c   Csathy, George S ^c   Dorey, Frederick ^c   Reiter, Robert E ^c   Aronson, William J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Cell cycle proteins; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROTEIN P27;

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELL LABELING; CONTROLLED STUDY; HEALTH STATUS; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECURRENCE RISK; RISK ASSESSMENT; SCORING SYSTEM; TIME; TUMOR BIOPSY;

EID: 0037376644     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000054004.08958.f3     Document Type: Article

References (22)

1. Kattan, M. W., Eastham, J. A., Stapleton, A. M., Wheeler, T. M. and Scardino, P. T.: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst, 90: 766, 1998
2. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
3. Freedland, S. J., Csathy, G. S., Dorey, F. and Aronson, W. J.: Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol, 167: 516, 2002
4. Harding, M. A. and Theodorescu, D.: Prognostic markers in localized prostate cancer: from microscopes to molecules. Cancer Metastasis Rev, 17: 429, 1998
5. Moul, J. W., Kane, C. J. and Malkowicz, S. B.: The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy. Urol Clin North Am, 28: 459, 2001
6. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P. et al: Cloning of p27Kip1, a cyclindependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59, 1994
7. Sgambato, A., Cittadini, A., Faraglia, B. and Weinstein, I. B.: Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol, 183: 18, 2000
8. kip1 and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. J Urol, 164: 2156, 2000
9. Yang, R. M., Naitoh, J., Murphy, M., Wang, H.-J., Phillipson, J., deKernion, J. B. et al: Low P27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol, 159: 941, 1998
10. Cheng, L., Lloyd, R. V., Weaver, A. L., Pisansky, T. M., Cheville, J. C., Ramnani, D. M. et al: The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res, 6: 1896, 2000
11. Erdamar, S., Yang, G., Harper, J. W., Lu, X., Kattan, M. W., Thompson, T. C. et al: Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis. Mod Pathol, 12: 751, 1999
12. Cote, R. J., Shi, Y., Groshen, S., Feng, A. C., Cordon-Cardo, C., Skinner, D. et al: Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst, 90: 916, 1998
13. Cheville, J. C., Lloyd, R. V., Sebo, T. J., Cheng, L., Erickson, L., Bostwick, D. G. et al: Expression of p27kip1 in prostatic adenocarcinoma. Mod Pathol, 11: 324, 1998
14. Tsihlias, J., Kapusta, L. R., DeBoer, G., Morava-Protzner, I., Zbieranowski, I., Bhattacharya, N. et al: Loss of cyclindependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res, 58: 542, 1998
15. Kuczyk, M., Machtens, S., Hradil, K., Schubach, J., Christian, W., Knuchel, R. et al: Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients. Br J Cancer, 81: 1052, 1999
16. Thomas, G. V., Schrage, M. I., Rosenfelt, L., Kim, J. H., Salur, G., deKernion, J. B. et al: Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage. J Urol, 164: 1987, 2000
17. Beahrs, O. H., Henson, D. E. and Hutter, R. V. P.: American Joint Committee on Cancer Manual for Staging Cancer. Philadelphia: J. B. Lippincott, 1992
18. Gleason, D. F.: Classification of prostatic carcinomas. Cancer Chemother Rep, 50: 125, 1966
19. Freedland, S. J., Dorey, F. and Aronson, W. J.: Multivariate analysis of race and adverse pathologic findings after radical prostatectomy. Urology, 56: 807, 2000
20. Freedland, S. J., Jalkut, M., Dorey, F., Sutter, M. E. and Aronson, W. J.: Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology, 56: 87, 2000
21. Hall, G. S., Kramer, C. E. and Epstein, J. I.: Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol, 16: 315, 1992
22. Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. and Pandolfi, P. P.: Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet, 27: 222, 2001